gasilalfa.blogg.se - Fus protein scaffold and client

#FUS PROTEIN SCAFFOLD AND CLIENT HOW TO#
#FUS PROTEIN SCAFFOLD AND CLIENT PDF#

101000181722 FUS Proteins 0.000 title claims abstract description 22.108009000433 Amyotrophic lateral sclerosis (ALS) Proteins 0.000 title claims abstract description 23.108020004707 nucleic acids Proteins 0.000 title claims abstract description 75.150000007523 nucleic acids Chemical class 0.000 title claims abstract description 89.Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Universite de Strasbourg filed Critical Institut National de la Sante et de la Recherche Medicale INSERM Priority to EP20315141.0A priority Critical patent/EP3892283A1/en Publication of EP3892283A1 publication Critical patent/EP3892283A1/en Status Pending legal-status Critical Current Links Original Assignee Institut National de la Sante et de la Recherche Medicale INSERM Universite de Strasbourg Priority date (The priority date is an assumption and is not a legal conclusion. Institut National de la Sante et de la Recherche Medicale INSERM Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Inventor Luc Dupuis Immaculada Sanjuan Ruiz Gina PICCHIARELLI Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Pending Application number EP20315141.0A Other languages German ( de)

#FUS PROTEIN SCAFFOLD AND CLIENT PDF#

Google Patents Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (als)ĭownload PDF Info Publication number EP3892283A1 EP3892283A1 EP20315141.0A EP20315141A EP3892283A1 EP 3892283 A1 EP3892283 A1 EP 3892283A1 EP 20315141 A EP20315141 A EP 20315141A EP 3892283 A1 EP3892283 A1 EP 3892283A1 Authority EP European Patent Office Prior art keywords fus seq sequence nucleic acid mice Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents EP3892283A1 - Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (als) They also found that co-culture with bovine smooth muscle cells and tri-culture with bovine endothelial cells – cells that line the interior surface of blood vessels and lymphatic vessels – created an enhanced meat-like texture.Īccording to volunteers who tested the product after cooking, its taste, aroma and texture were typical of real meat.EP3892283A1 - Nucleic acids encoding human fus protein and use in the treatment of amyotrophic lateral sclerosis (als) Researchers found that bovine satellite cells, which are “seeded” within the textured soy protein scaffolds where they multiply and create tissue, covered a large portion of the scaffolds.

Subscribe to the Science Focus Podcast on these services: Acast, iTunes, Stitcher, RSS, Overcast.

They say it is a cost-effective, edible and porous protein-based material. Shulamit Levenberg, from the Israel Institute of Technology, and colleagues describe a new method to create a 3D scaffold out of textured soy protein. The scaffold also needs to be edible and have suitable nutritional value and texture. Its creation requires a 3D scaffold to support the engineered cells and mimic the environment in which animal muscles grow.

5 things you probably didn't know about processed foodĬultured, or cell-based, meat is an evolving technology that could generate meat without the need for animal agriculture.

The future of food: what we’ll eat in 2028.

#FUS PROTEIN SCAFFOLD AND CLIENT HOW TO#

How to grow food in space: the Antarctic base preparing for human space colonies.The study, published in Nature Food, found the product performed well in preliminary taste tests.